Open-label use of an aliphatic polyamine immunomodulator in patients hospitalized with COVID-19

dc.contributor.author	Efimov, S. V.
dc.contributor.author	Matsiyeuskaya, N. V.
dc.contributor.author	Boytsova, O. V.
dc.contributor.author	Akhieva, L. Yu.
dc.contributor.author	Kuntsevich, E. V.
dc.contributor.author	Troshina, A. A.
dc.contributor.author	Kvasova, E. I.
dc.contributor.author	Tikhonov, A. A.
dc.contributor.author	Khomyakova, N. F.
dc.contributor.author	Harrison, F.
dc.contributor.author	Rossi, J.-F.
dc.contributor.author	Hardman, T. C.
dc.date.accessioned	2024-06-24T07:13:48Z
dc.date.available	2024-06-24T07:13:48Z
dc.date.issued	2022
dc.identifier.citation	Open-label use of an aliphatic polyamine immunomodulator in patients hospitalized with COVID-19 / S. V. Efimov, N. V. Matsiyeuskaya, O. V. Boytsova, L. Yu. Akhieva, E. V. Kuntsevich, A. A. Troshina, E. I. Kvasova, A. A. Tikhonov, N. F. Khomyakova, F. Harrison, J.-F. Rossi, T. C. Hardman // Drugs Context. – 2022. – Vol. 11. – P. 1-15.	ru_RU
dc.identifier.uri	http://elib.grsmu.by/handle/files/33201
dc.language.iso	en	ru_RU
dc.title	Open-label use of an aliphatic polyamine immunomodulator in patients hospitalized with COVID-19	ru_RU
dc.type	Article	ru_RU